Sant Pau - Institut de Recerca

Main lines of research

Medical care projects.
Study of pathogenic mechanisms altering body fat distribution.
Study of metabolic disorders associated with antiretroviral treatment.
Body composition changes.
New antiretroviral drugs.
Cardiovascular risk associated with antiretroviral treatment.
Comorbid conditions associated with HIV-1 infection.
Pharmacogenetics (toxicokinetics).
Bacterial meningitis.

Challenges

Medical care projects

Continuing with, expanding and, as appropriate, consolidating the care team for HIV-1 infected patients, consisting currently of 3 staff physicians, 4 grantaided research assistants (including a Río Hortega-funded research assistant) and 2 nurses).
Continuing with participation in multicentre projects (especially the AIDS network, Gesida, VACH, EuroSIDA and ART collaboration).
Exploration of possible participation in clinical trials of new antiretroviral drugs.
Increasing the number of HIV-1 infected patients attended to in our hospital (given current mortality rates, an estimated annual increase of 50 patients is required).
Continuing with current clinical research and mixed basic reserch-clinical research lines.

Pathogenic mechanisms altering body fat distribution

Study of metabolism in pyrimidines and derivatives in the genesis of lipodystrophy associated with HIV-1 and antiretroviral treatment.
Development of an animal (mouse) model of lipodystrophy.
Development of in vitro models (adipocyte cultures) to study the adipose toxicity of antiretroviral drugs.
Study of new manifestations of the lipodystrophy syndrome.
Development of measurements for antiretroviral drug concentrations in adipose tissue.
Exploration of the role of inflammation in the pathogenesis of lipodystrophy associated with HIV-1 and antiretroviral treatment.
Metabolism of uridine and its role in the pathogenesis of lipodystrophy.

Metabolic disorders associated with antiretroviral treatment

In vivo assessment of metabolic toxicity associated with antiretroviral treatment.
Development of in vitro models (adipocyte cultures) to study the adipose toxicity of antiretroviral drugs.
Study of factors contributing factors to hepatic steatosis in patients receiving antiretroviral treatment.
Study of the pathogenic role of FGF21 in insulin resistance in HIV-1- infected patients.
Study of role of FABP4 in metabolic disorders associated with antiretroviral treatment.

Body composition

Definition of normal fat distribution in the general population.
Establishment of abnormal fat distribution patterns.
Development of a definition of lipodystrophy associated with HIV-1 and antiretroviral treatment.

New antiretrovirals drugs

Clinical trials of new antiretroviral drugs (phases 2 and 3).
Ritonavir and non-ritonavir pharmacokinetic potentiation ofantiretroviral drugs.

Cardiovascular risk associated with antiretroviral treatment

Establishment of a multicentre cardiovascular risk cohort.
Study of antiretroviral treatmentdependent and non treatmentdependent factors in multicentre cohorts.
Development of in vitro models (adipose cultures) to study adipose toxicity for antiretroviral drugs.

Comorbid conditions associated with HIV-1 infection

Study of ageing in different tissues associated with HIV-1 infection and antiretroviral treatment.
Study of fragility in patients with HIV-1 infection and the role of HAART.
Evaluation of the neurocognitive function in patients with HIV-1 infection with and without antiretroviral treatment.
Participation in multicentre cohort studies to determine the incidence of specific comorbidities (cancer, HCV, cardiovascular disease, osteogenesis/osteoporosis): EuroSIDA, ART Collaboration, Gesida, VACH, etc.
Treatment of HCV in patients with HIV-1 and its prognostic significance.

Pharmacogenetics (toxicogenetics)

Role of enzyme polymorphism of the pyrimidine pathways in the pathogenesis of lipodystrophy.
Role of enzyme polymorphism of the pyrimidine pathways in the pathogenesis of clinical toxicity (neuropathy, pancreatitis).
Role of IL28B polymorphism in spontaneous HCV clearance in the response to antiviral treatment based on interferon and ribavirin.

Bacterial meningitis

Identification of prognostic factors in adult bacterial meningitis.
Continuation with a cohort study of adult bacterial meningitis.
Identification of host-intrinsic factors in the in the pathogenesis
and prognosis of adult bacterial meningitis and meningococcal
disease.

Group coordination

DOMINGO PEDROL, PERE FGS
pdomingo@santpau.cat

Members

Herrera Bachs, Silvia IR

Millan Revilla, Lucia IR

Muñoz Rodriguez, Jessica IR

Quesada Lopez, Tania Paloma IR

Publications 2022

(JIF 2022)

Amele S, Sandri AK, Rodger A, Vandekerckhove L, Benfield T, Milinkovic A, Duvivier C, Stellbrink HJ, Sambatakou H, Chkhartishvili N, Caldeira L, Laguno M, Domingo P, Wandeler G, Gisinger M, Kuzovatova E, Dragovic G, Knysz B, Matulionyte R, Rockstroh JK, Lundgren JD, Mocroft A, Peters L. HCV reinfection after HCV therapy among HIV/HCV-coinfected individuals in Europe. HIV MEDICINE. 2022; 23(6). DOI:10.1111/hiv.13212. PMID:34882940. IF:3 (Q3/7D). Document type: Article.
Calabria M, Garcia C, Grunden N, Pons C, Arroyo JA, Gomez B, Garcia M, Belvis R, Morollon N, Igual JV, Mur I, Pomar V, Domingo P. Post-COVID-19 fatigue: the contribution of cognitive and neuropsychiatric symptoms. JOURNAL OF NEUROLOGY. 2022; 269(8). DOI:10.1007/s00415-022-11141-8. PMID:35488918. IF:6 (Q1/2D). Document type: Article.
Calvet J, Berenguer A, Gay M, Massanella M, Domingo P, Llop M, Sanchez E, Arevalo M, Carrillo J, Albinana N, Arauz G, Orellana C, Delgado JF, Serrano A, Llobell A, Graell E, Garcia M, Moreno M, Galisteo C, Casado E, Navarro N, Gomez A, Garcia S, Rusinol M, Costa E, Clotet B, Vilaseca M, Blanco J, Gratacos J. Biomarker candidates for progression and clinical management of COVID-19 associated pneumonia at time of admission. Scientific Reports. 2022; 12(1):640. DOI:10.1038/s41598-021-04683-w. PMID:35022497. IF:4,6 (Q2/3D). Document type: Article.
Castellvi I, Castillo D, Corominas H, Mariscal A, Orozco S, Benito N, Pomar V, Baucells A, Mur I, de la Rosa D, Lobo D, Millan AM, de Sosa NH, Filella D, Matas L, Martinez L, Juarez C, Casademont J, Domingo P. Krebs von den Lungen-6 glycoprotein circulating levels are not useful as prognostic marker in COVID-19 pneumonia: A large prospective cohort study. Frontiers in Medicine. 2022; 9:973918. DOI:10.3389/fmed.2022.973918. PMID:36004366. IF:3,9 (Q2/4D). Document type: Article.
Castro A, Diaz P, Domingo P, Garcia C, Losa JE, Castro A, Vidal N, Aceituno S. Analysis of the costs associated with the follow-up of HIV patients discontinuing antiretroviral treatment due to lack of effectiveness or unacceptable toxicity in Spain. Farmacia Hospitalaria. 2022; 46(6). DOI:10.7399/fh.13038. PMID:36520571. Document type: Article.
Collazos J, Domingo P, Fernandez N, Asensi E, Vilchez H, Lalueza A, Roy E, Blanes R, Raya M, Sanz J, Artero A, Ramos JM, Duenas C, Lamas JL, Asensi V, Valproic Acid COVID GRP. Exposure to valproic acid is associated with less pulmonary infiltrates and improvements in diverse clinical outcomes and laboratory parameters in patients hospitalized with COVID-19. PLoS One. 2022; 17(1):e0262777. DOI:10.1371/journal.pone.0262777. PMID:35085321. IF:3,7 (Q2/4D). Document type: Article.
Cozzi A, Peters L, Pelchen A, Neesgaard B, Stephan C, Elbirt D, Brännström J, Paduta D, Trofimova T, Szlavik J, Van V, Pai H, Lundgren J, Harxhi A, Losso M, Kundro M, Schmied B, Karpov I, Vassilenko A, Paduto D, Mitsura VM, Clumeck N, De Wit S, Delforge M, Hadziosmanovic V, Begovac J, Machala L, Jilich D, Gerstoft J, Pedersen C, Sedlacek D, et al. [Domingo P], for the EuroSIDA Study Group. Observational cohort study of rilpivirine (RPV) utilization in Europe. AIDS Research and Therapy. 2022; 19(1):38. DOI:10.1186/s12981-022-00457-0. PMID:35933352. IF:2,2 (Q4/8D). Document type: Article.
De Dios A, Masip M, Pagès N, Riera P, Mateo MG, Del Mar M, Mangues MA, Gomis M. Desarrollo de una intervención mHealth para rediseñar la ruta asistencial de las personas que viven con VIH: Estudio cualitativo. Farmacia Hospitalaria. 2022; 46. DOI:10.7399/fh.13249. PMID:36520560. Document type: Article.
Domingo P, Giralt M, Gavalda A, Blasco A, Delgado A, Gallego JM, Gutierrez MD, Mateo MG, Cereijo R, Domingo JC, Villarroya F, Villarroya J. Adipose tissue aging partially accounts for fat alterations in HIV lipodystrophy. 2022; 11(1):2042962. DOI:10.1080/21623945.2022.2042962. PMID:35300561. IF:3,3 (Q3/6D). Document type: Article.
Domingo P, Mateo MG, Villarroya J, Cereijo R, Torres F, Domingo JC, Campderros L, Gallego JM, Gutierrez MD, Mur I, Corbacho N, Vidal F, Villarroya F, Giralt M. Increased Circulating Levels of Growth Differentiation Factor 15 in Association with Metabolic Disorders in People Living with HIV Receiving Combined Antiretroviral Therapy. Journal of Clinical Medicine. 2022; 11(3):549. DOI:10.3390/jcm11030549. PMID:35160008. IF:3,9 (Q2/4D). Document type: Article.
Domingo P, Quesada T, Villarroya J, Cairo M, Gutierrez MD, Mateo MG, Mur I, Corbacho N, Domingo JC, Villarroya F, Giralt M. Differential effects of dolutegravir, bictegravir and raltegravir in adipokines and inflammation markers on human adipocytes. LIFE SCIENCES. 2022; 308:120948. DOI:10.1016/j.lfs.2022.120948. PMID:36096241. IF:6,1 (Q1/2D). Document type: Article.
Fanciulli C, Berenguer J, Busca C, Vivancos MJ, Tellez MJ, Dominguez L, Domingo P, Navarro J, Santos J, Iribarren JA, Morano L, Artero A, Moreno J, Rivero A, Santos I, Giner L, Arminanzas C, Montero M, Manzardo C, Cifuentes C, Garcia C, Galindo MJ, Ferrero OL, Sanz J, de la Fuente B, Rodriguez C, Gaspar G, Perez L, Losa JE, Force L, Veloso S, Martinez E, Jarrin I, De Miguel M, Garcia JG. Epidemiological trends of HIV/HCV coinfection in Spain, 2015-2019. HIV MEDICINE. 2022; 23(7). DOI:10.1111/hiv.13229. PMID:35037379. IF:3 (Q3/7D). Document type: Article.
Franquet T, Domingo P. Pulmonary Infections in People Living with HIV. RADIOLOGIC CLINICS OF NORTH AMERICA. 2022; 60(3). DOI:10.1016/j.rcl.2022.01.008. PMID:35534134. IF:1,9 (Q3/8D). Document type: Review.
Franquet T, Gimenez A, Ketai L, Mazzini S, Rial A, Pomar V, Domingo P. Air trapping in COVID-19 patients following hospital discharge: retrospective evaluation with paired inspiratory/expiratory thin-section CT. EUROPEAN RADIOLOGY. 2022; 32(7). DOI:10.1007/s00330-022-08580-2. PMID:35226158. IF:5,9 (Q1/2D). Document type: Article.
Garcia C, Calabria M, Grunden N, Pons C, Arroyo JA, Gomez B, Lleo A, Alcolea D, Belvis R, Morollon N, Mur I, Pomar V, Domingo P. Neuropsychological deficits in patients with cognitive complaints after COVID-19. Brain and Behavior. 2022; 12(3):e2508. DOI:10.1002/brb3.2508. PMID:35137561. IF:2,5 (Q3/6D). Document type: Article.
Garcia C, Cereijo R, Plou C, Gavalda A, Malpique R, Villarroya J, Lopez A, de Zegher F, Ibanez L, Villarroya F. Posterior Cervical Brown Fat and CXCL14 Levels in the First Year of Life: Sex Differences and Association With Adiposity. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM. 2022; 107(3). DOI:10.1210/clinem/dgab761. PMID:34677618. IF:5,8 (Q1/3D). Document type: Article.
Garreta E, Prado P, Stanifer ML, Monteil V, Marco A, Ullate A, Moya D, Vilas A, Tarantino C, Romero JP, Jonsson G, Oria R, Leopoldi A, Hagelkruys A, Gallo M, González F, Domingo P, Gavaldà A, del Pozo CH, Hasan O, Ventura P, Campistol JM, Prosper F, Mirazimi A, Boulant S, Penninger JM, Montserrat N. A diabetic milieu increases ACE2 expression and cellular susceptibility to SARS-CoV-2 infections in human kidney organoids and patient cells. Cell Metabolism. 2022; 34(6). DOI:10.1016/j.cmet.2022.04.009. PMID:35561674. IF:29 (Q1/1D). Document type: Article.
Gavalda A, Villarroya J, Cereijo R, Giralt M, Villarroya F. The endocrine role of brown adipose tissue: An update on actors and actions. REVIEWS IN ENDOCRINE & METABOLIC DISORDERS. 2022; 23(1). DOI:10.1007/s11154-021-09640-6. PMID:33712997. IF:8,2 (Q1/1D). Document type: Review.
Llaurado G, Vlacho B, Wargny M, Ruan Y, Franch J, Domingo P, Gourdy P, Saulnier PJ, Hadjadj S, Wild SH, Rea R, Cariou B, Khunti K, Mauricio D. The association between macrovascular complications and intensive care admission, invasive mechanical ventilation, and mortality in people with diabetes hospitalized for coronavirus disease-2019 (COVID-19). Cardiovascular Diabetology. 2022; 21(1):216. DOI:10.1186/s12933-022-01657-8. PMID:36261811. IF:9,3 (Q1/1D). Document type: Article.
Martin R, Reyes J, Bruguera A, Aceitón J, Díaz Y, Moreno S, Domingo P, Burgos J, Tiraboschi JM, Johansen IS, Álvarez H, Miró JM, Casabona J, Llibre JM, PISCIS G. Determinants of long-term survival in late HIV presenters: The prospective PISCIS cohort study. Eclinicalmedicine. 2022; 52:101600. DOI:10.1016/j.eclinm.2022.101600. PMID:35958520. IF:15,1 (Q1/1D). Document type: Article.
Masip J, Jorba R, Lopez M, Domingo P, Pacheco YM, Garcia G, Martinez E, Vilades C, Veloso S, Alba V, Olona M, Vidal F, Gomez F, Peraire J, Rull A. Lipoprotein Profile in Immunological Non-Responders PLHIV after Antiretroviral Therapy Initiation. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES. 2022; 23(15):8071. DOI:10.3390/ijms23158071. PMID:35897644. IF:5,6 (Q1/3D). Document type: Article.
Mocroft A, Miro JM, Wandeler G, Llibre JM, Boyd A, van K, Beniowski M, Mikhalik J, Cavassini M, Maltez F, Duvivier C, Foppa CU, Knysz B, Bakowska E, Kuzovatova E, Domingo P, Zagalo A, Viard JP, Degen O, Milinkovic A, Benfield T, Peters L. The association between hepatitis B virus infection and nonliver malignancies in persons living with HIV: results from the EuroSIDA study. HIV MEDICINE. 2022; 23(6). DOI:10.1111/hiv.13210. PMID:34889022. IF:3 (Q3/7D). Document type: Article.
Moga E, Lynton E, Domingo P. The Robustness of Cellular Immunity Determines the Fate of SARS-CoV-2 Infection. Frontiers in Immunology. 2022; 13:904686. DOI:10.3389/fimmu.2022.904686. PMID:35833134. IF:7,3 (Q1/3D). Document type: Review.
Munoz J, Millan L. The role of nurses in the prevention of anal cancer in HIV- infected men having sex with men – a focus on papillomavirus vaccination and anal cytology screening. AIDS REVIEWS. 2022; 24(4). DOI:10.24875/AIDSRev.M22000053. PMID:36580603. IF:2,2 (Q4/8D). Document type: Review.
Nomah DK, Reyes J, Diaz Y, Moreno S, Aceiton J, Bruguera A, Vivanco RM, Casabona J, Domingo P, Navarro J, Imaz A, Deig E, Navarro G, Llibre JM, Miro JM, PISCIS GRP. Impact of tenofovir on SARS-CoV-2 infection and severe outcomes among people living with HIV: a propensity score-matched study. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY. 2022; 77(8). DOI:10.1093/jac/dkac177. PMID:35678461. IF:5,2 (Q1/2D). Document type: Article.
Podzamczer D, Mican R, Tiraboschi J, Portilla J, Domingo P, Llibre JM, Ribera E, Vivancos MJ, Morano L, Masia M, Gomez C, Fanjul F, Payeras A, Inciarte A, Estrada V, Rivero A, Castro A, Bernal E, Vinuesa D, Knobel H, Troya J, Macias J, Montero M, Sanz J, Navarro A, Caicedo A, Fernandez G, Martinez E, Moreno S, SYMTRI I. Darunavir/Cobicistat/Emtricitabine/Tenofovir Alafenamide Versus Dolutegravir/Abacavir/Lamivudine in Antiretroviral-Naive Adults (SYMTRI): A Multicenter Randomized Open-Label Study (PReEC/RIS-57). Open Forum Infectious Diseases. 2022; 9(3):ofab595. DOI:10.1093/ofid/ofab595. PMID:35237700. IF:4,2 (Q2/4D). Document type: Article.
Reyes D, Lopez J, Moga E, Pla F, Lynton E, Rojas R, Turon J, Querol L, Olive M, Alvarez R, Caballero M, Carbayo A, Vesperinas A, Domingo P, Illa I, Gallardo E, Cortes E. Immune Response and Safety of SARS-CoV-2 mRNA-1273 Vaccine in Patients With Myasthenia Gravis. Neurology-Neuroimmunology & Neuroinflammation. 2022; 9(4):e200002. DOI:10.1212/NXI.0000000000200002. PMID:35728947. IF:8,8 (Q1/1D). Document type: Article.
Riancho JA, Peris P, González J, Pérez JL, Cannata J, Cano A, Carbonell C, Casado E, Ciria M, Corral L, del Pino J, Del Río LM, Díaz M, Díez A, García A, Gómez C, Gómez de Tejada Romero MJ, Guañabens N, Hawkins F, Jódar E, Malouf J, Martínez Díaz G, Monegal A, Muñoz M, Naves M, Nogues X, Nolla JM, Olmos JM, Peris P, Quesada JM, Rodríguez M, Sosa M, Torrijos A, Valero Díaz de Lamadrid C, SEIOMM Osteoporosis Guidelines Writing G. Executive summary clinical practice guideline of postmenopausal, glucocorticoid-induced, and male osteoporosis (2022 update). Revista De Osteoporosis Y Metabolismo Mineral. 2022; 14(1). DOI:10.4321/S1889-836X2022000100002. Document type: Article.
Saumoy M, Sanchez JL, Assoumou L, Gatell JM, Gonzalez A, Guaraldi G, Domingo P, Giacomelli A, Connault J, Katlama C, Masia M, Ordonez J, Pozniak A, Martinez E, Podzamczer D. Atherogenicity of low-density lipoproteins after switching from a protease inhibitor to dolutegravir: a substudy of the NEAT022 study. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY. 2022; 77(7). DOI:10.1093/jac/dkac117. PMID:35411401. IF:5,2 (Q1/2D). Document type: Article/Practice guideline.
Spinner CD, Felizarta F, Rizzardini G, Philibert P, Mitha E, Domingo P, Stephan CJ, DeGrosky M, Bainbridge V, Zhan J, Dumitrescu TP, Jeffrey JL, Xu JF, Halliday F, Gan JJ, Johnson M, Gartland M, Joshi SR, Lataillade M, Study 208132. Phase IIa Proof-of-Concept Evaluation of the Antiviral Efficacy, Safety, Tolerability, and Pharmacokinetics of the Next-Generation Maturation Inhibitor GSK3640254. CLINICAL INFECTIOUS DISEASES. 2022; 75(5). DOI:10.1093/cid/ciab1065. PMID:34996113. IF:11,8 (Q1/1D). Document type: Article.
Trickey A, Zhang L, Gill MJ, Bonnet F, Burkholder G, Castagna A, Cavassini M, Cichon P, Crane H, Domingo P, Grabar S, Guest J, Obel N, Psichogiou M, Rava M, Reiss P, Rentsch CT, Riera M, Schuettfort G, Silverberg MJ, Smith C, Stecher M, Sterling TR, Ingle SM, Sabin CA, Sterne JAC. Associations of modern initial antiretroviral drug regimens with all-cause mortality in adults with HIV in Europe and North America: a cohort study. Lancet HIV. 2022; 9(6). DOI:10.1016/S2352-3018(22)00046-7. PMID:35659335. IF:16,1 (Q1/1D). Document type: Article.
Yeregui E, Masip J, Vilades C, Domingo P, Pacheco YM, Blanco J, Mallolas J, Alba V, Vargas M, Garcia G, Negredo E, Olona M, Vidal J, Peraire M, Marti A, Reverte L, Gomez F, Leal M, Vidal F, Peraire J, Rull A. Adipokines as New Biomarkers of Immune Recovery: Apelin Receptor, RBP4 and ZAG Are Related to CD4(+) T-Cell Reconstitution in PLHIV on Suppressive Antiretroviral Therapy. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES. 2022; 23(4):2202. DOI:10.3390/ijms23042202. PMID:35216318. IF:5,6 (Q1/3D). Document type: Article.

Publications 2021

Alserawan L, Penacoba P, Echevarria S, Castillo D, Ortiz E, Martinez L, Naranjo EM, Domingo P, Castellvi I, Juarez C, Mariscal A. Growth Differentiation Factor 15 (GDF-15): A Novel Biomarker Associated with Poorer Respiratory Function in COVID-19. Diagnostics. 2021; 11(11):1998. DOI:10.3390/diagnostics11111998. PMID:34829345. IF:3,992.
Amele S, Peters L, Rodger A, Lundgren J, Rockstroh J, Matulionyte R, Leen C, Jablonowska E, Ostergaard L, Bhagani S, Sarcletti M, Clarke A, Falconer K, Wandeler G, Domingo P, Maltez F, Zaccarelli M, Chkhartisvili N, Szlavik J, Stephan C, Fonquernie L, Aho I, Mocroft A, Group ES. Effectiveness and Safety of Interferon-Free Direct-Acting Antiviral Hepatitis C Virus Therapy in HIV/Hepatitis C Virus Coinfected Individuals: Results From a Pan-European Study. JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES. 2021; 86(2). DOI:10.1097/QAI.0000000000002541. PMID:33079903. IF:3,771.
Arroyo JA, Julve J, Vlacho B, Corcoy R, Ponte P, Roman E, Navas E, Llaurado G, Franch J, Domingo P, Mauricio D. Previous Vitamin D Supplementation and Morbidity and Mortality Outcomes in People Hospitalised for COVID19: A Cross-Sectional Study. Frontiers in Public Health. 2021; 9:758347. DOI:10.3389/fpubh.2021.758347. PMID:34631653. IF:6,461.
Berenguer J, Borobia AM, Ryan P, Rodriguez J, Bellon JM, Jarrin I, Carratala J, Pachon J, Carcas AJ, Yllescas M, Arribas JR, López J, Pascual P, Pomar V, Rabella N, Benito N, Domingo P, Bonfill X, Mancebo J, MARTIN A. Development and validation of a prediction model for 30-day mortality in hospitalised patients with COVID-19: the COVID-19 SEIMC score. THORAX. 2021; 76(9). DOI:10.1136/thoraxjnl-2020-216001. PMID:33632764. IF:9,102.
Brochado O, Martinez I, Berenguer J, Medrano L, Gonzalez J, Jimenez MA, Carrero A, Hontanon V, Navarro J, Guardiola JM, Fernandez A, Resino S, Domingo P, Esteban H. HCV eradication with IFN-based therapy does not completely restore gene expression in PBMCs from HIV/HCV-coinfected patients. JOURNAL OF BIOMEDICAL SCIENCE. 2021; 28(1):23. DOI:10.1186/s12929-021-00718-6. PMID:33785040. IF:12,771.
Camps A, Perez S, Subirana I, Teira R, Estrada V, Domingo P, Degano IR, Marrugat J. Standardized Comparison of Cardiovascular Risk Factors Prevalence in Spanish Women and Men Living with HIV and in the General Population. Journal of Personalized Medicine. 2021; 11(11):1085. DOI:10.3390/jpm11111085. PMID:34834438. IF:3,508.
Cereijo R, Quesada T, Gavalda A, Tarasco J, Pellitero S, Reyes M, Puig M, Giralt M, Sanchez D, Villarroya F. The chemokine CXCL14 is negatively associated with obesity and concomitant type-2 diabetes in humans. INTERNATIONAL JOURNAL OF OBESITY. 2021; 45(3). DOI:10.1038/s41366-020-00732-y. PMID:33414488. IF:5,551.
Corbacho N, Mur I, Molas ME, Vidal F, Domingo P. The pharmacological management of cardiovascular disease in people living with HIV (PLWH). EXPERT OPINION ON PHARMACOTHERAPY. 2021; 22(6). DOI:10.1080/14656566.2020.1856075. PMID:33283570. IF:4,103.
Corominas H, Castellvi I, Diaz C, Matas L, de la Rosa D, Mangues MA, Moya P, Pomar V, Benito N, Moga E, Hernandez N, Casademont J, Domingo P. Sarilumab (IL-6R antagonist) in critically ill patients with cytokine release syndrome by SARS-CoV2. MEDICINE. 2021; 100(19):e25923. DOI:10.1097/MD.0000000000025923. PMID:34106658. IF:1,817.
Corominas H, Castellvi I, Pomar V, Antonijoan R, Mur I, Matas L, Gich I, de Benito N, Laiz A, Castillo D, Villamarin L, Filella D, Mill AM, Quijada MA, Puig M, Casademont J, Domingo P. Effectiveness and safety of intravenous tocilizumab to treat COVID-19-associated hyperinflammatory syndrome: Covizumab-6 observational cohort. CLINICAL IMMUNOLOGY. 2021; 223:108631. DOI:10.1016/j.clim.2020.108631. PMID:33189888. IF:10,190.
Domingo P, Pomar V, Mur I, Castellvi I, Corominas H, de Benito N. Not all COVID-19 pandemic waves are alike. CLINICAL MICROBIOLOGY AND INFECTION. 2021; 27(7). DOI:10.1016/j.cmi.2021.04.005. PMID:33887469. IF:13,310.
Elias MJP, Alejos B, Gutierrez MM, Crespo M, Gil ID, Ribera E, Galindo MJ, Lozano F, Cifre AP, Boix V, Montero M, Sanz J, Lima JD, Palacios R, Moral SDF, Martinez E. Dynamics of creatinine estimated glomerular filtration rate using one or more antiretrovirals that inhibit creatinine tubular secretion. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY. 2021; 76(4). DOI:10.1093/jac/dkaa547. PMID:33501995. IF:5,758.
Fernández I, de Lazzari E, Inciarte A, Diaz-Brito V, Milinkovic A, Arenas-Pinto A, Etcheverrry F, García F, Leal L; HIV-PEP Group [Domingo P]. Network meta-analysis of post-exposure prophylaxis randomized clinical trials. HIV Medicine. 2021;22(3):218-224. DOI:10.1111/hiv.12964. PMID: 33108035. IF:3,094.
Gonzalez A, Assoumou L, Moyle G, Waters L, Johnson M, Domingo P, Fox J, Stellbrink HJ, Guaraldi G, Masia M, Gompels M, De Wit S, Florence E, Esser S, Raffi F, Behrens G, Pozniak A, Gatell JM, Martinez E. Switching from boosted PIs to dolutegravir decreases soluble CD14 and adiponectin in high cardiovascular risk people living with HIV. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY. 2021; 76(9). DOI:10.1093/jac/dkab158. PMID:34120186. IF:5,758.
Grau B, Camprubi D, Marti H, Fernandez M, Carreras C, Velasco M, Ferrer E, Muelas M, Jullien S, Barilaro G, Ajanovic S, Vera I, Moreno L, Gonzalez E, Cortes N, Roldan M, Artes A, Mur I, Domingo P, Garcia F, Guinovart C, Munoz J. Pre-exposure prophylaxis with hydroxychloroquine for COVID-19: a double-blind, placebo-controlled randomized clinical trial. Trials. 2021; 22(1):808. DOI:10.1186/s13063-021-05758-9. PMID:34781981. IF:2,728.
Gutierrez B, del Toro MD, Borobia AM, Carcas A, Jarrin I, Yllescas M, Ryan P, Pachon J, Carratala J, Berenguer J, Arribas JR, Rodriguez J, López J, Pascual P, Pomar V, Rabella N, Benito N, Domingo P, Bonfill X, Puig M, Mancebo J, Martinez G. Identification and validation of clinical phenotypes with prognostic implications in patients admitted to hospital with COVID-19: a multicentre cohort study. LANCET INFECTIOUS DISEASES. 2021; 21(6). DOI:10.1016/S1473-3099(21)00019-0. PMID:33636145. IF:71,421.
Gutierrez MD, Mur I, Mateo MG, Vidal F, Domingo P. Pharmacological considerations for the treatment of COVID-19 in people living with HIV (PLWH). EXPERT OPINION ON PHARMACOTHERAPY. 2021; 22(9). DOI:10.1080/14656566.2021.1887140. PMID:33634724. IF:4,103.
Kowalska JD, Pelchen A, Ryom L, Losso MH, Trofimova T, Mitsura VM, Khromova I, Paduta D, Stephan C, Domingo P, Bakowska E, Monforte AD, Oestergaard L, Jablonowska E, Kuznetsova A, Moreno S, Vasylyev M, Pradier C, Battegay M, Vandekerckhove L, Castagna A, Raben D, Mocroft A, EuroSIDA GRP. Prevalence and outcomes of pregnancies in women with HIV over a 20-year period. AIDS. 2021; 35(12). DOI:10.1097/QAD.0000000000002954. PMID:34033590. IF:4,632.
Nomah DK, Reyes J, Diaz Y, Moreno S, Aceiton J, Bruguera A, Vivanco RM, Llibre JM, Domingo P, Falco V, Imaz A, Cortes C, Force L, Letang E, Vilaro I, Casabona J, Miro JM, Mur I, Macorigh L. Sociodemographic, clinical, and immunological factors associated with SARS-CoV-2 diagnosis and severe COVID-19 outcomes in people living with HIV: a retrospective cohort study. Lancet HIV. 2021; 8(11). DOI:10.1016/S2352-3018(21)00240-X. PMID:34655549. IF:16,070.
Ortega E, Corcoy R, Gratacos M, Claramunt FXC, Mata M, Puig R, Real J, Vlacho B, Castelblanco E, Domingo P, Khunti K, Franch J, Mauricio D. Risk factors for severe outcomes in people with diabetes hospitalised for COVID-19: a cross-sectional database study. BMJ Open. 2021; 11(7):e051237. DOI:10.1136/bmjopen-2021-051237. PMID:34301668. IF:3,006.
Palacio J, Reyes JM, Imaz A, Bruguera A, Force L, Llaveria AO, Llibre JM, Vilaro I, Borras FH, Falco V, Riera M, Domingo P, de Lazzari E, Miro JM, Casabona J, Gurgui M, Hernandez J. Strategies to reengage patients lost to follow up in HIV care in high income countries, a scoping review. BMC PUBLIC HEALTH. 2021; 21(1):1596. DOI:10.1186/s12889-021-11613-y. PMID:34454444. IF:4,135.
Reyes M, Gonzalez L, Ibeas K, Cereijo R, Taxeras SD, Pellitero S, Martinez E, Tarasco J, Moreno P, Malagon P, Higueras C, Soria A, Puig M, Villarroya F, Serra D, Herrero L, Sanchez D. White adipose tissue-infiltrated CD11b+myeloid cells are a source of S100A4, a new potential marker of hepatic damage. EUROPEAN JOURNAL OF ENDOCRINOLOGY. 2021; 184(4). DOI:10.1530/EJE-20-1130. PMID:33524007. IF:6,558.
Rivera A, Sanchez A, Luque S, Mur I, Puig L, Crusi X, Gonzalez JC, Sorli L, Gonzalez A, Horcajada JP, Navarro F, Benito N. Intraoperative Bacterial Contamination and Activity of Different Antimicrobial Prophylaxis Regimens in Primary Knee and Hip Replacement. Antibiotics-Basel. 2021; 10(1):18. DOI:10.3390/antibiotics10010018. PMID:33375415. IF:5,222.
Rojas J, de Lazzari E, Negredo E, Domingo P, Tiraboschi J, Ribera E, Abdulghani N, Puig J, Mateo MG, Podzamczer D, Gutierrez MM, Paredes R, Clotet B, Gatell JM, Blanco JL, Martinez E, DOLAM GRP. Efficacy and safety of switching to dolutegravir plus lamivudine versus continuing triple antiretroviral therapy in virologically suppressed adults with HIV at 48 weeks (DOLAM): a randomised non-inferiority trial. Lancet HIV. 2021; 8(8). PMID:34358497. IF:16,070.
Shankar M, Vale CL, Godolphin PJ, Fisher D, Higgins JPT, Spiga F, Savovic J, Tierney J, Baron G, Benbenishty JS, Berry LR, Broman N, Cavalcanti AB, Colman R, De Buyser SL, Derde LPG, Domingo P, Omar SF, Fernandez A, Feuth T, Garcia F, Garcia R, Gonzalez I, Gordon AC, Haynes R, Hermine O, Horby PW, Horick NK, Kumar K, Lambrecht BN, et al. [Pomar V, Benito N]. Association Between Administration of IL-6 Antagonists and Mortality Among Patients Hospitalized for COVID-19 AMeta-analysis. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION. 2021; 326(6). DOI:10.1001/jama.2021.11330. PMID:34228774. IF:157,335.
Teira R, Diaz H, Aragao F, Marguet S, de la Fuente B, Munoz MJ, Abdulghani N, Ribera E, Domingo P, Deig E, Peraire J, Roca B, Montero M, Galindo MJ, Romero A, Espinosa N, Lozano F, Merino MD, Martinez E, Geijo P, Estrada V, Garcia J, Sepulveda MA, Berenguer J. Real world effectiveness of standard of care triple therapy versus two-drug combinations for treatment of people living with HIV. PLoS One. 2021; 16(4):e0249515. DOI:10.1371/journal.pone.0249515. PMID:33831047. IF:3,752.
Teira R, Diaz H, Aragao F, Munoz J, Galindo P, Merino M, de la Fuente B, Sepulveda MA, Domingo P, Garcia J, Castano M, Ribera E, Geijo P, Romero A, Peraire J, Deig E, Roca B, Martinez E, Estrada V, Montero M, Berenguer J, Espinosa N. eGFR-EPI changes among HIV patients who switch from F/TDF to F/TAF while maintaining the same third agent in the Spanish VACH cohort. HIV Research & Clinical Practice. 2021; 22(3). DOI:10.1080/25787489.2021.1955197. PMID:34410219. IF:1,676.
Urraza AI, Giralt M, Gonzalez FF, Villarroya F, Perez A, Flores PR, Perez M, Domingo P, Lopez FC. FGF21 serum levels are related to insulin resistance, metabolic changes and obesity in Mexican people living with HIV (PLWH). PLoS One. 2021; 16(5):e0252144. DOI:10.1371/journal.pone.0252144. PMID:34019585. IF:3,752.
Vilchez HH, Escudero R, Fernandez M, Murillo O, Aunon A, Rodriguez D, Jover A, del Toro MD, Rico A, Falgueras L, Praena J, Guio L, Iribarren JA, Lora J, Benito N, Morata L, Ramirez A, Riera M, Mur I, Coll P, Crusi X, Soriano A. Prosthetic Shoulder Joint Infection by Cutibacterium acnes: Does Rifampin Improve Prognosis? A Retrospective, Multicenter, Observational Study. Antibiotics-Basel. 2021; 10(5):475. DOI:10.3390/antibiotics10050475. PMID:33919103. IF:5,222.

2017 Scientific Report – Research Group in HIV

Introduction

Main lines of research

Medical care projects.
Study of pathogenic mechanisms altering body fat distribution.
Study of metabolic disorders associated with antiretroviral treatment.
Body composition changes.
New antiretroviral drugs.
Cardiovascular risk associated with antiretroviral treatment.
Comorbid conditions associated with HIV-1 infection.
Pharmacogenetics (toxicokinetics).
Bacterial meningitis.

Challenges

Medical care projects

Continuing with, expanding and, as appropriate, consolidating the care team for HIV-1 infected patients, consisting currently of 3 staff physicians, 4 grantaided research assistants (including a Río Hortega-funded research assistant) and 2 nurses).
Continuing with participation in multicentre projects (especially the AIDS network, Gesida, VACH, EuroSIDA and ART collaboration).
Exploration of possible participation in clinical trials of new antiretroviral drugs.
Increasing the number of HIV-1 infected patients attended to in our hospital (given current mortality rates, an estimated annual increase of 50 patients is required).
Continuing with current clinical research and mixed basic reserch-clinical research lines.

Pathogenic mechanisms altering body fat distribution

Study of metabolism in pyrimidines and derivatives in the genesis of lipodystrophy associated with HIV-1 and antiretroviral treatment.
Development of an animal (mouse) model of lipodystrophy.
Development of in vitro models (adipocyte cultures) to study the adipose toxicity of antiretroviral drugs.
Study of new manifestations of the lipodystrophy syndrome.
Development of measurements for antiretroviral drug concentrations in adipose tissue.
Exploration of the role of inflammation in the pathogenesis of lipodystrophy associated with HIV-1 and antiretroviral treatment.
Metabolism of uridine and its role in the pathogenesis of lipodystrophy.

Metabolic disorders associated with antiretroviral treatment

In vivo assessment of metabolic toxicity associated with antiretroviral treatment.
Development of in vitro models (adipocyte cultures) to study the adipose toxicity of antiretroviral drugs.
Study of factors contributing factors to hepatic steatosis in patients receiving antiretroviral treatment.
Study of the pathogenic role of FGF21 in insulin resistance in HIV-1- infected patients.
Study of role of FABP4 in metabolic disorders associated with antiretroviral treatment.

Body composition

Definition of normal fat distribution in the general population.
Establishment of abnormal fat distribution patterns.
Development of a definition of lipodystrophy associated with HIV-1 and antiretroviral treatment.

New antiretrovirals drugs

Clinical trials of new antiretroviral drugs (phases 2 and 3).
Ritonavir and non-ritonavir pharmacokinetic potentiation ofantiretroviral drugs.

Cardiovascular risk associated with antiretroviral treatment

Establishment of a multicentre cardiovascular risk cohort.
Study of antiretroviral treatmentdependent and non treatmentdependent factors in multicentre cohorts.
Development of in vitro models (adipose cultures) to study adipose toxicity for antiretroviral drugs.

Comorbid conditions associated with HIV-1 infection

Study of ageing in different tissues associated with HIV-1 infection and antiretroviral treatment.
Study of fragility in patients with HIV-1 infection and the role of HAART.
Evaluation of the neurocognitive function in patients with HIV-1 infection with and without antiretroviral treatment.
Participation in multicentre cohort studies to determine the incidence of specific comorbidities (cancer, HCV, cardiovascular disease, osteogenesis/osteoporosis): EuroSIDA, ART Collaboration, Gesida, VACH, etc.
Treatment of HCV in patients with HIV-1 and its prognostic significance.

Pharmacogenetics (toxicogenetics)

Role of enzyme polymorphism of the pyrimidine pathways in the pathogenesis of lipodystrophy.
Role of enzyme polymorphism of the pyrimidine pathways in the pathogenesis of clinical toxicity (neuropathy, pancreatitis).
Role of IL28B polymorphism in spontaneous HCV clearance in the response to antiviral treatment based on interferon and ribavirin.

Bacterial meningitis

Identification of prognostic factors in adult bacterial meningitis.
Continuation with a cohort study of adult bacterial meningitis.
Identification of host-intrinsic factors in the in the pathogenesis
and prognosis of adult bacterial meningitis and meningococcal
disease.

Team

Group coordination

DOMINGO PEDROL, PERE FGS
pdomingo@santpau.cat

Members

Herrera Bachs, Silvia IR

Millan Revilla, Lucia IR

Muñoz Rodriguez, Jessica IR

Quesada Lopez, Tania Paloma IR

Scientific output

Publications 2022

(JIF 2022)

Amele S, Sandri AK, Rodger A, Vandekerckhove L, Benfield T, Milinkovic A, Duvivier C, Stellbrink HJ, Sambatakou H, Chkhartishvili N, Caldeira L, Laguno M, Domingo P, Wandeler G, Gisinger M, Kuzovatova E, Dragovic G, Knysz B, Matulionyte R, Rockstroh JK, Lundgren JD, Mocroft A, Peters L. HCV reinfection after HCV therapy among HIV/HCV-coinfected individuals in Europe. HIV MEDICINE. 2022; 23(6). DOI:10.1111/hiv.13212. PMID:34882940. IF:3 (Q3/7D). Document type: Article.
Calabria M, Garcia C, Grunden N, Pons C, Arroyo JA, Gomez B, Garcia M, Belvis R, Morollon N, Igual JV, Mur I, Pomar V, Domingo P. Post-COVID-19 fatigue: the contribution of cognitive and neuropsychiatric symptoms. JOURNAL OF NEUROLOGY. 2022; 269(8). DOI:10.1007/s00415-022-11141-8. PMID:35488918. IF:6 (Q1/2D). Document type: Article.
Calvet J, Berenguer A, Gay M, Massanella M, Domingo P, Llop M, Sanchez E, Arevalo M, Carrillo J, Albinana N, Arauz G, Orellana C, Delgado JF, Serrano A, Llobell A, Graell E, Garcia M, Moreno M, Galisteo C, Casado E, Navarro N, Gomez A, Garcia S, Rusinol M, Costa E, Clotet B, Vilaseca M, Blanco J, Gratacos J. Biomarker candidates for progression and clinical management of COVID-19 associated pneumonia at time of admission. Scientific Reports. 2022; 12(1):640. DOI:10.1038/s41598-021-04683-w. PMID:35022497. IF:4,6 (Q2/3D). Document type: Article.
Castellvi I, Castillo D, Corominas H, Mariscal A, Orozco S, Benito N, Pomar V, Baucells A, Mur I, de la Rosa D, Lobo D, Millan AM, de Sosa NH, Filella D, Matas L, Martinez L, Juarez C, Casademont J, Domingo P. Krebs von den Lungen-6 glycoprotein circulating levels are not useful as prognostic marker in COVID-19 pneumonia: A large prospective cohort study. Frontiers in Medicine. 2022; 9:973918. DOI:10.3389/fmed.2022.973918. PMID:36004366. IF:3,9 (Q2/4D). Document type: Article.
Castro A, Diaz P, Domingo P, Garcia C, Losa JE, Castro A, Vidal N, Aceituno S. Analysis of the costs associated with the follow-up of HIV patients discontinuing antiretroviral treatment due to lack of effectiveness or unacceptable toxicity in Spain. Farmacia Hospitalaria. 2022; 46(6). DOI:10.7399/fh.13038. PMID:36520571. Document type: Article.
Collazos J, Domingo P, Fernandez N, Asensi E, Vilchez H, Lalueza A, Roy E, Blanes R, Raya M, Sanz J, Artero A, Ramos JM, Duenas C, Lamas JL, Asensi V, Valproic Acid COVID GRP. Exposure to valproic acid is associated with less pulmonary infiltrates and improvements in diverse clinical outcomes and laboratory parameters in patients hospitalized with COVID-19. PLoS One. 2022; 17(1):e0262777. DOI:10.1371/journal.pone.0262777. PMID:35085321. IF:3,7 (Q2/4D). Document type: Article.
Cozzi A, Peters L, Pelchen A, Neesgaard B, Stephan C, Elbirt D, Brännström J, Paduta D, Trofimova T, Szlavik J, Van V, Pai H, Lundgren J, Harxhi A, Losso M, Kundro M, Schmied B, Karpov I, Vassilenko A, Paduto D, Mitsura VM, Clumeck N, De Wit S, Delforge M, Hadziosmanovic V, Begovac J, Machala L, Jilich D, Gerstoft J, Pedersen C, Sedlacek D, et al. [Domingo P], for the EuroSIDA Study Group. Observational cohort study of rilpivirine (RPV) utilization in Europe. AIDS Research and Therapy. 2022; 19(1):38. DOI:10.1186/s12981-022-00457-0. PMID:35933352. IF:2,2 (Q4/8D). Document type: Article.
De Dios A, Masip M, Pagès N, Riera P, Mateo MG, Del Mar M, Mangues MA, Gomis M. Desarrollo de una intervención mHealth para rediseñar la ruta asistencial de las personas que viven con VIH: Estudio cualitativo. Farmacia Hospitalaria. 2022; 46. DOI:10.7399/fh.13249. PMID:36520560. Document type: Article.
Domingo P, Giralt M, Gavalda A, Blasco A, Delgado A, Gallego JM, Gutierrez MD, Mateo MG, Cereijo R, Domingo JC, Villarroya F, Villarroya J. Adipose tissue aging partially accounts for fat alterations in HIV lipodystrophy. 2022; 11(1):2042962. DOI:10.1080/21623945.2022.2042962. PMID:35300561. IF:3,3 (Q3/6D). Document type: Article.
Domingo P, Mateo MG, Villarroya J, Cereijo R, Torres F, Domingo JC, Campderros L, Gallego JM, Gutierrez MD, Mur I, Corbacho N, Vidal F, Villarroya F, Giralt M. Increased Circulating Levels of Growth Differentiation Factor 15 in Association with Metabolic Disorders in People Living with HIV Receiving Combined Antiretroviral Therapy. Journal of Clinical Medicine. 2022; 11(3):549. DOI:10.3390/jcm11030549. PMID:35160008. IF:3,9 (Q2/4D). Document type: Article.
Domingo P, Quesada T, Villarroya J, Cairo M, Gutierrez MD, Mateo MG, Mur I, Corbacho N, Domingo JC, Villarroya F, Giralt M. Differential effects of dolutegravir, bictegravir and raltegravir in adipokines and inflammation markers on human adipocytes. LIFE SCIENCES. 2022; 308:120948. DOI:10.1016/j.lfs.2022.120948. PMID:36096241. IF:6,1 (Q1/2D). Document type: Article.
Fanciulli C, Berenguer J, Busca C, Vivancos MJ, Tellez MJ, Dominguez L, Domingo P, Navarro J, Santos J, Iribarren JA, Morano L, Artero A, Moreno J, Rivero A, Santos I, Giner L, Arminanzas C, Montero M, Manzardo C, Cifuentes C, Garcia C, Galindo MJ, Ferrero OL, Sanz J, de la Fuente B, Rodriguez C, Gaspar G, Perez L, Losa JE, Force L, Veloso S, Martinez E, Jarrin I, De Miguel M, Garcia JG. Epidemiological trends of HIV/HCV coinfection in Spain, 2015-2019. HIV MEDICINE. 2022; 23(7). DOI:10.1111/hiv.13229. PMID:35037379. IF:3 (Q3/7D). Document type: Article.
Franquet T, Domingo P. Pulmonary Infections in People Living with HIV. RADIOLOGIC CLINICS OF NORTH AMERICA. 2022; 60(3). DOI:10.1016/j.rcl.2022.01.008. PMID:35534134. IF:1,9 (Q3/8D). Document type: Review.
Franquet T, Gimenez A, Ketai L, Mazzini S, Rial A, Pomar V, Domingo P. Air trapping in COVID-19 patients following hospital discharge: retrospective evaluation with paired inspiratory/expiratory thin-section CT. EUROPEAN RADIOLOGY. 2022; 32(7). DOI:10.1007/s00330-022-08580-2. PMID:35226158. IF:5,9 (Q1/2D). Document type: Article.
Garcia C, Calabria M, Grunden N, Pons C, Arroyo JA, Gomez B, Lleo A, Alcolea D, Belvis R, Morollon N, Mur I, Pomar V, Domingo P. Neuropsychological deficits in patients with cognitive complaints after COVID-19. Brain and Behavior. 2022; 12(3):e2508. DOI:10.1002/brb3.2508. PMID:35137561. IF:2,5 (Q3/6D). Document type: Article.
Garcia C, Cereijo R, Plou C, Gavalda A, Malpique R, Villarroya J, Lopez A, de Zegher F, Ibanez L, Villarroya F. Posterior Cervical Brown Fat and CXCL14 Levels in the First Year of Life: Sex Differences and Association With Adiposity. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM. 2022; 107(3). DOI:10.1210/clinem/dgab761. PMID:34677618. IF:5,8 (Q1/3D). Document type: Article.
Garreta E, Prado P, Stanifer ML, Monteil V, Marco A, Ullate A, Moya D, Vilas A, Tarantino C, Romero JP, Jonsson G, Oria R, Leopoldi A, Hagelkruys A, Gallo M, González F, Domingo P, Gavaldà A, del Pozo CH, Hasan O, Ventura P, Campistol JM, Prosper F, Mirazimi A, Boulant S, Penninger JM, Montserrat N. A diabetic milieu increases ACE2 expression and cellular susceptibility to SARS-CoV-2 infections in human kidney organoids and patient cells. Cell Metabolism. 2022; 34(6). DOI:10.1016/j.cmet.2022.04.009. PMID:35561674. IF:29 (Q1/1D). Document type: Article.
Gavalda A, Villarroya J, Cereijo R, Giralt M, Villarroya F. The endocrine role of brown adipose tissue: An update on actors and actions. REVIEWS IN ENDOCRINE & METABOLIC DISORDERS. 2022; 23(1). DOI:10.1007/s11154-021-09640-6. PMID:33712997. IF:8,2 (Q1/1D). Document type: Review.
Llaurado G, Vlacho B, Wargny M, Ruan Y, Franch J, Domingo P, Gourdy P, Saulnier PJ, Hadjadj S, Wild SH, Rea R, Cariou B, Khunti K, Mauricio D. The association between macrovascular complications and intensive care admission, invasive mechanical ventilation, and mortality in people with diabetes hospitalized for coronavirus disease-2019 (COVID-19). Cardiovascular Diabetology. 2022; 21(1):216. DOI:10.1186/s12933-022-01657-8. PMID:36261811. IF:9,3 (Q1/1D). Document type: Article.
Martin R, Reyes J, Bruguera A, Aceitón J, Díaz Y, Moreno S, Domingo P, Burgos J, Tiraboschi JM, Johansen IS, Álvarez H, Miró JM, Casabona J, Llibre JM, PISCIS G. Determinants of long-term survival in late HIV presenters: The prospective PISCIS cohort study. Eclinicalmedicine. 2022; 52:101600. DOI:10.1016/j.eclinm.2022.101600. PMID:35958520. IF:15,1 (Q1/1D). Document type: Article.
Masip J, Jorba R, Lopez M, Domingo P, Pacheco YM, Garcia G, Martinez E, Vilades C, Veloso S, Alba V, Olona M, Vidal F, Gomez F, Peraire J, Rull A. Lipoprotein Profile in Immunological Non-Responders PLHIV after Antiretroviral Therapy Initiation. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES. 2022; 23(15):8071. DOI:10.3390/ijms23158071. PMID:35897644. IF:5,6 (Q1/3D). Document type: Article.
Mocroft A, Miro JM, Wandeler G, Llibre JM, Boyd A, van K, Beniowski M, Mikhalik J, Cavassini M, Maltez F, Duvivier C, Foppa CU, Knysz B, Bakowska E, Kuzovatova E, Domingo P, Zagalo A, Viard JP, Degen O, Milinkovic A, Benfield T, Peters L. The association between hepatitis B virus infection and nonliver malignancies in persons living with HIV: results from the EuroSIDA study. HIV MEDICINE. 2022; 23(6). DOI:10.1111/hiv.13210. PMID:34889022. IF:3 (Q3/7D). Document type: Article.
Moga E, Lynton E, Domingo P. The Robustness of Cellular Immunity Determines the Fate of SARS-CoV-2 Infection. Frontiers in Immunology. 2022; 13:904686. DOI:10.3389/fimmu.2022.904686. PMID:35833134. IF:7,3 (Q1/3D). Document type: Review.
Munoz J, Millan L. The role of nurses in the prevention of anal cancer in HIV- infected men having sex with men – a focus on papillomavirus vaccination and anal cytology screening. AIDS REVIEWS. 2022; 24(4). DOI:10.24875/AIDSRev.M22000053. PMID:36580603. IF:2,2 (Q4/8D). Document type: Review.
Nomah DK, Reyes J, Diaz Y, Moreno S, Aceiton J, Bruguera A, Vivanco RM, Casabona J, Domingo P, Navarro J, Imaz A, Deig E, Navarro G, Llibre JM, Miro JM, PISCIS GRP. Impact of tenofovir on SARS-CoV-2 infection and severe outcomes among people living with HIV: a propensity score-matched study. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY. 2022; 77(8). DOI:10.1093/jac/dkac177. PMID:35678461. IF:5,2 (Q1/2D). Document type: Article.
Podzamczer D, Mican R, Tiraboschi J, Portilla J, Domingo P, Llibre JM, Ribera E, Vivancos MJ, Morano L, Masia M, Gomez C, Fanjul F, Payeras A, Inciarte A, Estrada V, Rivero A, Castro A, Bernal E, Vinuesa D, Knobel H, Troya J, Macias J, Montero M, Sanz J, Navarro A, Caicedo A, Fernandez G, Martinez E, Moreno S, SYMTRI I. Darunavir/Cobicistat/Emtricitabine/Tenofovir Alafenamide Versus Dolutegravir/Abacavir/Lamivudine in Antiretroviral-Naive Adults (SYMTRI): A Multicenter Randomized Open-Label Study (PReEC/RIS-57). Open Forum Infectious Diseases. 2022; 9(3):ofab595. DOI:10.1093/ofid/ofab595. PMID:35237700. IF:4,2 (Q2/4D). Document type: Article.
Reyes D, Lopez J, Moga E, Pla F, Lynton E, Rojas R, Turon J, Querol L, Olive M, Alvarez R, Caballero M, Carbayo A, Vesperinas A, Domingo P, Illa I, Gallardo E, Cortes E. Immune Response and Safety of SARS-CoV-2 mRNA-1273 Vaccine in Patients With Myasthenia Gravis. Neurology-Neuroimmunology & Neuroinflammation. 2022; 9(4):e200002. DOI:10.1212/NXI.0000000000200002. PMID:35728947. IF:8,8 (Q1/1D). Document type: Article.
Riancho JA, Peris P, González J, Pérez JL, Cannata J, Cano A, Carbonell C, Casado E, Ciria M, Corral L, del Pino J, Del Río LM, Díaz M, Díez A, García A, Gómez C, Gómez de Tejada Romero MJ, Guañabens N, Hawkins F, Jódar E, Malouf J, Martínez Díaz G, Monegal A, Muñoz M, Naves M, Nogues X, Nolla JM, Olmos JM, Peris P, Quesada JM, Rodríguez M, Sosa M, Torrijos A, Valero Díaz de Lamadrid C, SEIOMM Osteoporosis Guidelines Writing G. Executive summary clinical practice guideline of postmenopausal, glucocorticoid-induced, and male osteoporosis (2022 update). Revista De Osteoporosis Y Metabolismo Mineral. 2022; 14(1). DOI:10.4321/S1889-836X2022000100002. Document type: Article.
Saumoy M, Sanchez JL, Assoumou L, Gatell JM, Gonzalez A, Guaraldi G, Domingo P, Giacomelli A, Connault J, Katlama C, Masia M, Ordonez J, Pozniak A, Martinez E, Podzamczer D. Atherogenicity of low-density lipoproteins after switching from a protease inhibitor to dolutegravir: a substudy of the NEAT022 study. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY. 2022; 77(7). DOI:10.1093/jac/dkac117. PMID:35411401. IF:5,2 (Q1/2D). Document type: Article/Practice guideline.
Spinner CD, Felizarta F, Rizzardini G, Philibert P, Mitha E, Domingo P, Stephan CJ, DeGrosky M, Bainbridge V, Zhan J, Dumitrescu TP, Jeffrey JL, Xu JF, Halliday F, Gan JJ, Johnson M, Gartland M, Joshi SR, Lataillade M, Study 208132. Phase IIa Proof-of-Concept Evaluation of the Antiviral Efficacy, Safety, Tolerability, and Pharmacokinetics of the Next-Generation Maturation Inhibitor GSK3640254. CLINICAL INFECTIOUS DISEASES. 2022; 75(5). DOI:10.1093/cid/ciab1065. PMID:34996113. IF:11,8 (Q1/1D). Document type: Article.
Trickey A, Zhang L, Gill MJ, Bonnet F, Burkholder G, Castagna A, Cavassini M, Cichon P, Crane H, Domingo P, Grabar S, Guest J, Obel N, Psichogiou M, Rava M, Reiss P, Rentsch CT, Riera M, Schuettfort G, Silverberg MJ, Smith C, Stecher M, Sterling TR, Ingle SM, Sabin CA, Sterne JAC. Associations of modern initial antiretroviral drug regimens with all-cause mortality in adults with HIV in Europe and North America: a cohort study. Lancet HIV. 2022; 9(6). DOI:10.1016/S2352-3018(22)00046-7. PMID:35659335. IF:16,1 (Q1/1D). Document type: Article.
Yeregui E, Masip J, Vilades C, Domingo P, Pacheco YM, Blanco J, Mallolas J, Alba V, Vargas M, Garcia G, Negredo E, Olona M, Vidal J, Peraire M, Marti A, Reverte L, Gomez F, Leal M, Vidal F, Peraire J, Rull A. Adipokines as New Biomarkers of Immune Recovery: Apelin Receptor, RBP4 and ZAG Are Related to CD4(+) T-Cell Reconstitution in PLHIV on Suppressive Antiretroviral Therapy. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES. 2022; 23(4):2202. DOI:10.3390/ijms23042202. PMID:35216318. IF:5,6 (Q1/3D). Document type: Article.

Publications 2021

Alserawan L, Penacoba P, Echevarria S, Castillo D, Ortiz E, Martinez L, Naranjo EM, Domingo P, Castellvi I, Juarez C, Mariscal A. Growth Differentiation Factor 15 (GDF-15): A Novel Biomarker Associated with Poorer Respiratory Function in COVID-19. Diagnostics. 2021; 11(11):1998. DOI:10.3390/diagnostics11111998. PMID:34829345. IF:3,992.
Amele S, Peters L, Rodger A, Lundgren J, Rockstroh J, Matulionyte R, Leen C, Jablonowska E, Ostergaard L, Bhagani S, Sarcletti M, Clarke A, Falconer K, Wandeler G, Domingo P, Maltez F, Zaccarelli M, Chkhartisvili N, Szlavik J, Stephan C, Fonquernie L, Aho I, Mocroft A, Group ES. Effectiveness and Safety of Interferon-Free Direct-Acting Antiviral Hepatitis C Virus Therapy in HIV/Hepatitis C Virus Coinfected Individuals: Results From a Pan-European Study. JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES. 2021; 86(2). DOI:10.1097/QAI.0000000000002541. PMID:33079903. IF:3,771.
Arroyo JA, Julve J, Vlacho B, Corcoy R, Ponte P, Roman E, Navas E, Llaurado G, Franch J, Domingo P, Mauricio D. Previous Vitamin D Supplementation and Morbidity and Mortality Outcomes in People Hospitalised for COVID19: A Cross-Sectional Study. Frontiers in Public Health. 2021; 9:758347. DOI:10.3389/fpubh.2021.758347. PMID:34631653. IF:6,461.
Berenguer J, Borobia AM, Ryan P, Rodriguez J, Bellon JM, Jarrin I, Carratala J, Pachon J, Carcas AJ, Yllescas M, Arribas JR, López J, Pascual P, Pomar V, Rabella N, Benito N, Domingo P, Bonfill X, Mancebo J, MARTIN A. Development and validation of a prediction model for 30-day mortality in hospitalised patients with COVID-19: the COVID-19 SEIMC score. THORAX. 2021; 76(9). DOI:10.1136/thoraxjnl-2020-216001. PMID:33632764. IF:9,102.
Brochado O, Martinez I, Berenguer J, Medrano L, Gonzalez J, Jimenez MA, Carrero A, Hontanon V, Navarro J, Guardiola JM, Fernandez A, Resino S, Domingo P, Esteban H. HCV eradication with IFN-based therapy does not completely restore gene expression in PBMCs from HIV/HCV-coinfected patients. JOURNAL OF BIOMEDICAL SCIENCE. 2021; 28(1):23. DOI:10.1186/s12929-021-00718-6. PMID:33785040. IF:12,771.
Camps A, Perez S, Subirana I, Teira R, Estrada V, Domingo P, Degano IR, Marrugat J. Standardized Comparison of Cardiovascular Risk Factors Prevalence in Spanish Women and Men Living with HIV and in the General Population. Journal of Personalized Medicine. 2021; 11(11):1085. DOI:10.3390/jpm11111085. PMID:34834438. IF:3,508.
Cereijo R, Quesada T, Gavalda A, Tarasco J, Pellitero S, Reyes M, Puig M, Giralt M, Sanchez D, Villarroya F. The chemokine CXCL14 is negatively associated with obesity and concomitant type-2 diabetes in humans. INTERNATIONAL JOURNAL OF OBESITY. 2021; 45(3). DOI:10.1038/s41366-020-00732-y. PMID:33414488. IF:5,551.
Corbacho N, Mur I, Molas ME, Vidal F, Domingo P. The pharmacological management of cardiovascular disease in people living with HIV (PLWH). EXPERT OPINION ON PHARMACOTHERAPY. 2021; 22(6). DOI:10.1080/14656566.2020.1856075. PMID:33283570. IF:4,103.
Corominas H, Castellvi I, Diaz C, Matas L, de la Rosa D, Mangues MA, Moya P, Pomar V, Benito N, Moga E, Hernandez N, Casademont J, Domingo P. Sarilumab (IL-6R antagonist) in critically ill patients with cytokine release syndrome by SARS-CoV2. MEDICINE. 2021; 100(19):e25923. DOI:10.1097/MD.0000000000025923. PMID:34106658. IF:1,817.
Corominas H, Castellvi I, Pomar V, Antonijoan R, Mur I, Matas L, Gich I, de Benito N, Laiz A, Castillo D, Villamarin L, Filella D, Mill AM, Quijada MA, Puig M, Casademont J, Domingo P. Effectiveness and safety of intravenous tocilizumab to treat COVID-19-associated hyperinflammatory syndrome: Covizumab-6 observational cohort. CLINICAL IMMUNOLOGY. 2021; 223:108631. DOI:10.1016/j.clim.2020.108631. PMID:33189888. IF:10,190.
Domingo P, Pomar V, Mur I, Castellvi I, Corominas H, de Benito N. Not all COVID-19 pandemic waves are alike. CLINICAL MICROBIOLOGY AND INFECTION. 2021; 27(7). DOI:10.1016/j.cmi.2021.04.005. PMID:33887469. IF:13,310.
Elias MJP, Alejos B, Gutierrez MM, Crespo M, Gil ID, Ribera E, Galindo MJ, Lozano F, Cifre AP, Boix V, Montero M, Sanz J, Lima JD, Palacios R, Moral SDF, Martinez E. Dynamics of creatinine estimated glomerular filtration rate using one or more antiretrovirals that inhibit creatinine tubular secretion. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY. 2021; 76(4). DOI:10.1093/jac/dkaa547. PMID:33501995. IF:5,758.
Fernández I, de Lazzari E, Inciarte A, Diaz-Brito V, Milinkovic A, Arenas-Pinto A, Etcheverrry F, García F, Leal L; HIV-PEP Group [Domingo P]. Network meta-analysis of post-exposure prophylaxis randomized clinical trials. HIV Medicine. 2021;22(3):218-224. DOI:10.1111/hiv.12964. PMID: 33108035. IF:3,094.
Gonzalez A, Assoumou L, Moyle G, Waters L, Johnson M, Domingo P, Fox J, Stellbrink HJ, Guaraldi G, Masia M, Gompels M, De Wit S, Florence E, Esser S, Raffi F, Behrens G, Pozniak A, Gatell JM, Martinez E. Switching from boosted PIs to dolutegravir decreases soluble CD14 and adiponectin in high cardiovascular risk people living with HIV. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY. 2021; 76(9). DOI:10.1093/jac/dkab158. PMID:34120186. IF:5,758.
Grau B, Camprubi D, Marti H, Fernandez M, Carreras C, Velasco M, Ferrer E, Muelas M, Jullien S, Barilaro G, Ajanovic S, Vera I, Moreno L, Gonzalez E, Cortes N, Roldan M, Artes A, Mur I, Domingo P, Garcia F, Guinovart C, Munoz J. Pre-exposure prophylaxis with hydroxychloroquine for COVID-19: a double-blind, placebo-controlled randomized clinical trial. Trials. 2021; 22(1):808. DOI:10.1186/s13063-021-05758-9. PMID:34781981. IF:2,728.
Gutierrez B, del Toro MD, Borobia AM, Carcas A, Jarrin I, Yllescas M, Ryan P, Pachon J, Carratala J, Berenguer J, Arribas JR, Rodriguez J, López J, Pascual P, Pomar V, Rabella N, Benito N, Domingo P, Bonfill X, Puig M, Mancebo J, Martinez G. Identification and validation of clinical phenotypes with prognostic implications in patients admitted to hospital with COVID-19: a multicentre cohort study. LANCET INFECTIOUS DISEASES. 2021; 21(6). DOI:10.1016/S1473-3099(21)00019-0. PMID:33636145. IF:71,421.
Gutierrez MD, Mur I, Mateo MG, Vidal F, Domingo P. Pharmacological considerations for the treatment of COVID-19 in people living with HIV (PLWH). EXPERT OPINION ON PHARMACOTHERAPY. 2021; 22(9). DOI:10.1080/14656566.2021.1887140. PMID:33634724. IF:4,103.
Kowalska JD, Pelchen A, Ryom L, Losso MH, Trofimova T, Mitsura VM, Khromova I, Paduta D, Stephan C, Domingo P, Bakowska E, Monforte AD, Oestergaard L, Jablonowska E, Kuznetsova A, Moreno S, Vasylyev M, Pradier C, Battegay M, Vandekerckhove L, Castagna A, Raben D, Mocroft A, EuroSIDA GRP. Prevalence and outcomes of pregnancies in women with HIV over a 20-year period. AIDS. 2021; 35(12). DOI:10.1097/QAD.0000000000002954. PMID:34033590. IF:4,632.
Nomah DK, Reyes J, Diaz Y, Moreno S, Aceiton J, Bruguera A, Vivanco RM, Llibre JM, Domingo P, Falco V, Imaz A, Cortes C, Force L, Letang E, Vilaro I, Casabona J, Miro JM, Mur I, Macorigh L. Sociodemographic, clinical, and immunological factors associated with SARS-CoV-2 diagnosis and severe COVID-19 outcomes in people living with HIV: a retrospective cohort study. Lancet HIV. 2021; 8(11). DOI:10.1016/S2352-3018(21)00240-X. PMID:34655549. IF:16,070.
Ortega E, Corcoy R, Gratacos M, Claramunt FXC, Mata M, Puig R, Real J, Vlacho B, Castelblanco E, Domingo P, Khunti K, Franch J, Mauricio D. Risk factors for severe outcomes in people with diabetes hospitalised for COVID-19: a cross-sectional database study. BMJ Open. 2021; 11(7):e051237. DOI:10.1136/bmjopen-2021-051237. PMID:34301668. IF:3,006.
Palacio J, Reyes JM, Imaz A, Bruguera A, Force L, Llaveria AO, Llibre JM, Vilaro I, Borras FH, Falco V, Riera M, Domingo P, de Lazzari E, Miro JM, Casabona J, Gurgui M, Hernandez J. Strategies to reengage patients lost to follow up in HIV care in high income countries, a scoping review. BMC PUBLIC HEALTH. 2021; 21(1):1596. DOI:10.1186/s12889-021-11613-y. PMID:34454444. IF:4,135.
Reyes M, Gonzalez L, Ibeas K, Cereijo R, Taxeras SD, Pellitero S, Martinez E, Tarasco J, Moreno P, Malagon P, Higueras C, Soria A, Puig M, Villarroya F, Serra D, Herrero L, Sanchez D. White adipose tissue-infiltrated CD11b+myeloid cells are a source of S100A4, a new potential marker of hepatic damage. EUROPEAN JOURNAL OF ENDOCRINOLOGY. 2021; 184(4). DOI:10.1530/EJE-20-1130. PMID:33524007. IF:6,558.
Rivera A, Sanchez A, Luque S, Mur I, Puig L, Crusi X, Gonzalez JC, Sorli L, Gonzalez A, Horcajada JP, Navarro F, Benito N. Intraoperative Bacterial Contamination and Activity of Different Antimicrobial Prophylaxis Regimens in Primary Knee and Hip Replacement. Antibiotics-Basel. 2021; 10(1):18. DOI:10.3390/antibiotics10010018. PMID:33375415. IF:5,222.
Rojas J, de Lazzari E, Negredo E, Domingo P, Tiraboschi J, Ribera E, Abdulghani N, Puig J, Mateo MG, Podzamczer D, Gutierrez MM, Paredes R, Clotet B, Gatell JM, Blanco JL, Martinez E, DOLAM GRP. Efficacy and safety of switching to dolutegravir plus lamivudine versus continuing triple antiretroviral therapy in virologically suppressed adults with HIV at 48 weeks (DOLAM): a randomised non-inferiority trial. Lancet HIV. 2021; 8(8). PMID:34358497. IF:16,070.
Shankar M, Vale CL, Godolphin PJ, Fisher D, Higgins JPT, Spiga F, Savovic J, Tierney J, Baron G, Benbenishty JS, Berry LR, Broman N, Cavalcanti AB, Colman R, De Buyser SL, Derde LPG, Domingo P, Omar SF, Fernandez A, Feuth T, Garcia F, Garcia R, Gonzalez I, Gordon AC, Haynes R, Hermine O, Horby PW, Horick NK, Kumar K, Lambrecht BN, et al. [Pomar V, Benito N]. Association Between Administration of IL-6 Antagonists and Mortality Among Patients Hospitalized for COVID-19 AMeta-analysis. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION. 2021; 326(6). DOI:10.1001/jama.2021.11330. PMID:34228774. IF:157,335.
Teira R, Diaz H, Aragao F, Marguet S, de la Fuente B, Munoz MJ, Abdulghani N, Ribera E, Domingo P, Deig E, Peraire J, Roca B, Montero M, Galindo MJ, Romero A, Espinosa N, Lozano F, Merino MD, Martinez E, Geijo P, Estrada V, Garcia J, Sepulveda MA, Berenguer J. Real world effectiveness of standard of care triple therapy versus two-drug combinations for treatment of people living with HIV. PLoS One. 2021; 16(4):e0249515. DOI:10.1371/journal.pone.0249515. PMID:33831047. IF:3,752.
Teira R, Diaz H, Aragao F, Munoz J, Galindo P, Merino M, de la Fuente B, Sepulveda MA, Domingo P, Garcia J, Castano M, Ribera E, Geijo P, Romero A, Peraire J, Deig E, Roca B, Martinez E, Estrada V, Montero M, Berenguer J, Espinosa N. eGFR-EPI changes among HIV patients who switch from F/TDF to F/TAF while maintaining the same third agent in the Spanish VACH cohort. HIV Research & Clinical Practice. 2021; 22(3). DOI:10.1080/25787489.2021.1955197. PMID:34410219. IF:1,676.
Urraza AI, Giralt M, Gonzalez FF, Villarroya F, Perez A, Flores PR, Perez M, Domingo P, Lopez FC. FGF21 serum levels are related to insulin resistance, metabolic changes and obesity in Mexican people living with HIV (PLWH). PLoS One. 2021; 16(5):e0252144. DOI:10.1371/journal.pone.0252144. PMID:34019585. IF:3,752.
Vilchez HH, Escudero R, Fernandez M, Murillo O, Aunon A, Rodriguez D, Jover A, del Toro MD, Rico A, Falgueras L, Praena J, Guio L, Iribarren JA, Lora J, Benito N, Morata L, Ramirez A, Riera M, Mur I, Coll P, Crusi X, Soriano A. Prosthetic Shoulder Joint Infection by Cutibacterium acnes: Does Rifampin Improve Prognosis? A Retrospective, Multicenter, Observational Study. Antibiotics-Basel. 2021; 10(5):475. DOI:10.3390/antibiotics10050475. PMID:33919103. IF:5,222.

ASSOCIATED GROUPS

Research Group in HIV and AIDS

Main lines of research

Challenges

Medical care projects

Pathogenic mechanisms altering body fat distribution

Metabolic disorders associated with antiretroviral treatment

Body composition

New antiretrovirals drugs

Cardiovascular risk associated with antiretroviral treatment

Comorbid conditions associated with HIV-1 infection

Pharmacogenetics (toxicogenetics)

Bacterial meningitis

Group coordination

Members

Publications 2022

Publications 2021

Main lines of research

Challenges

Medical care projects

Pathogenic mechanisms altering body fat distribution

Metabolic disorders associated with antiretroviral treatment

Body composition

New antiretrovirals drugs

Cardiovascular risk associated with antiretroviral treatment

Comorbid conditions associated with HIV-1 infection

Pharmacogenetics (toxicogenetics)

Bacterial meningitis

Group coordination

Members

Publications 2022

Publications 2021

Institut de Recerca de l’Hospital de la Santa Creu i Sant Pau